Search

everythinglearnresearchcommunity

for

Search:↓

Dapagliflozin improved blood sugar control in a man with Werner syndrome without side effects.

Tamsulosin with Serenoa repens is as effective as with 5-alpha-reductase inhibitors but causes fewer side effects.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

The nanofiber membranes effectively promote wound healing and have strong antibacterial properties.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Upadacitinib may effectively treat resistant lichen planopilaris.

Anwuligan may help treat hair loss by promoting hair growth.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Flavonoids in Iraqi marshland plants have potential health benefits like antioxidant and anti-inflammatory effects.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Diabetex improves diabetic wound healing better than metformin.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

Deucravacitinib helped a man regrow hair significantly.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

The new delivery method for dutasteride is more effective and has fewer side effects.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Tofacitinib is effective and safe for treating severe alopecia areata.

Baricitinib effectively reduces hair loss in severe alopecia areata and is generally safe.

The consensus provides guidelines for safely stopping danazol in hereditary angioedema treatment.

A new method improves betulin delivery in experiments, showing promise against certain tumors.